Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15558)
All Articles published online
|
Publishing Process of This Article
|
Dec 8, 2015 (publication date) through Mar 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yuan L, Bambha K. Bile acid receptors and nonalcoholic fatty liver disease. World J Hepatol 2015; 7(28): 2811-2818 [PMID: 26668692 DOI: 10.4254/wjh.v7.i28.2811] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i28/2811.htm |
| Number | Citing Articles |
| 1 |
Renchao Dong, Junqiao Wang, Xiaoguang Gao, Changyuan Wang, Kexin Liu, Jingjing Wu, Zhihao Liu, Huijun Sun, Xiaodong Ma, Qiang Meng. Yangonin protects against estrogen–induced cholestasis in a farnesoid X receptor-dependent manner. European Journal of Pharmacology 2019; 857: 172461 doi: 10.1016/j.ejphar.2019.172461
|
| 2 |
Xinyu Li, Tao Han, Shixuan Zheng, Guoyao Wu. Recent Advances in Animal Nutrition and Metabolism. Advances in Experimental Medicine and Biology 2022; 1354: 207 doi: 10.1007/978-3-030-85686-1_11
|
| 3 |
William P. Esler, Kendra K. Bence. Metabolic Targets in Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2019; 8(2): 247 doi: 10.1016/j.jcmgh.2019.04.007
|
| 4 |
Yun Li, Huiqin Hou, Xianglu Wang, Xin Dai, Wanru Zhang, Qiang Tang, Yue Dong, Chen Yan, Bangmao Wang, Zhengxiang Li, Hailong Cao. Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.796590
|
| 5 |
Weijun Lun, Qihao Yan, Xinghua Guo, Minchuan Zhou, Yan Bai, Jincan He, Hua Cao, Qishi Che, Jiao Guo, Zhengquan Su. Mechanism of action of the bile acid receptor TGR5 in obesity. Acta Pharmaceutica Sinica B 2024; 14(2): 468 doi: 10.1016/j.apsb.2023.11.011
|
| 6 |
Tao Chen, Nicholas William Reich, Noah Bell, Patricia D. Finn, David Rodriguez, Jill Kohler, Kenji Kozuka, Limin He, Andrew G. Spencer, Dominique Charmot, Marc Navre, Christopher W. Carreras, Samantha Koo-McCoy, Jocelyn Tabora, Jeremy S. Caldwell, Jeffrey W. Jacobs, Jason Gustaf Lewis. Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5). Journal of Medicinal Chemistry 2018; 61(17): 7589 doi: 10.1021/acs.jmedchem.8b00308
|
| 7 |
Xingting Xue, Hongbing Zhou, Jiaxing Gao, Xinghua Li, Jia Wang, Wanfu Bai, Yingchun Bai, Liya Fan, Hong Chang, Songli Shi. The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review. Heliyon 2024; 10(19): e38339 doi: 10.1016/j.heliyon.2024.e38339
|
| 8 |
Mariana Machado, Helena Cortez-Pinto. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. International Journal of Molecular Sciences 2016; 17(4): 481 doi: 10.3390/ijms17040481
|
| 9 |
Dongming Qi, Tingting Zheng, Maosen Yang, Zhiying Huang, Tao Wang, Qiang Wang, Binlong Chen. Bile Acid Composition and Transcriptome Analysis of the Liver and Small Intestine in Different Species. Metabolites 2024; 14(8): 451 doi: 10.3390/metabo14080451
|
| 10 |
Adel Bensalem, Babar Murtaza, Aziz Hichami, Amira Sayed Khan, Hayet Oulamara, Gregory Merlen, Mustapha Berrichi, Abdel-Nacer Agli, Thierry Tordjmann, Naim Akhtar Khan. Bile acid receptor TGR5 is critically involved in preference for dietary lipids and obesity. The Journal of Nutritional Biochemistry 2020; 76: 108298 doi: 10.1016/j.jnutbio.2019.108298
|
| 11 |
Renchao Dong, Xiaobo Yang, Changyuan Wang, Kexin Liu, Zhihao Liu, Xiaodong Ma, Huijun Sun, Xiaokui Huo, Ting Fu, Qiang Meng. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor. Phytomedicine 2019; 53: 134 doi: 10.1016/j.phymed.2018.09.006
|
| 12 |
Patricia D. Finn, David Rodriguez, Jill Kohler, Zhengfeng Jiang, Sindy Wan, Erick Blanco, Andrew J. King, Tao Chen, Noah Bell, Dean Dragoli, Jeffrey W. Jacobs, Rakesh Jain, Michael Leadbetter, Matthew Siegel, Christopher W. Carreras, Samantha Koo-McCoy, Karen Shaw, Cathy Le, Sandra Vanegas, I-Hsin Hsu, Kenji Kozuka, Keiko Okamoto, Jeremy S. Caldwell, Jason G. Lewis. Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 316(3): G412 doi: 10.1152/ajpgi.00300.2018
|
| 13 |
Richard Radun, Michael Trauner. Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities. Seminars in Liver Disease 2021; 41(04): 461 doi: 10.1055/s-0041-1731707
|
| 14 |
Raphael Chevre, Laia Trigueros‐Motos, David Castaño, Tricia Chua, Maria Corlianò, Jay V. Patankar, Lareina Sng, Lauren Sim, Tan Liang Juin, Guillaume Carissimo, Lisa F. P. Ng, Cheryl Neo Jia Yi, Chelsea Chandani Eliathamby, Albert K. Groen, Michael R. Hayden, Roshni R. Singaraja. Therapeutic modulation of the bile acid pool byCyp8b1knockdown protects against nonalcoholic fatty liver disease in mice. The FASEB Journal 2018; 32(7): 3792 doi: 10.1096/fj.201701084RR
|
| 15 |
Jinhyuk Na, Soo An Choi, Adnan Khan, Joo Young Huh, Lingjuan Piao, Inah Hwang, Hunjoo Ha, Youngja H Park. Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice. Biomolecules & Therapeutics 2019; 27(2): 134 doi: 10.4062/biomolther.2018.175
|
| 16 |
Valeria Iannone, Johnson Lok, Ambrin Farizah Babu, Carlos Gómez-Gallego, Roosa Maria Willman, Ville Mikael Koistinen, Anton Klåvus, Mikko I. Kettunen, Anna Kårlund, Ursula Schwab, Kati Hanhineva, Marjukka Kolehmainen, Hani El-Nezami. Associations of altered hepatic gene expression in American lifestyle-induced obesity syndrome diet-fed mice with metabolic changes during NAFLD development and progression. The Journal of Nutritional Biochemistry 2023; 115: 109307 doi: 10.1016/j.jnutbio.2023.109307
|
| 17 |
Junping Zheng, Cheng Ye, Baifei Hu, Huabing Yang, Qunfeng Yao, Jun Ma, Yang Liu, Hongtao Liu. Bile acid profiles in bile and feces of obese mice by a high‐performance liquid chromatography–tandem mass spectrometry. Biotechnology and Applied Biochemistry 2020; doi: 10.1002/bab.2055
|
| 18 |
Sayuri Takada, Tsutomu Matsubara, Hideki Fujii, Misako Sato-Matsubara, Atsuko Daikoku, Naoshi Odagiri, Yuga Amano-Teranishi, Norifumi Kawada, Kazuo Ikeda. Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. Laboratory Investigation 2021; 101(2): 193 doi: 10.1038/s41374-020-00509-x
|
| 19 |
Adrian P. Mansini, Estanislao Peixoto, Kristen M. Thelen, Cesar Gaspari, Sujeong Jin, Sergio A. Gradilone. The cholangiocyte primary cilium in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1245 doi: 10.1016/j.bbadis.2017.06.006
|
| 20 |
Yu Zhang, Hongbing Xie, Lirong Wang, Jianhe Hu, Lei Wang, Shouping Zhang. Effect of Weaning at 21 Days of Age on the Content of Bile Acids in Chyme of Cecum. Animals 2022; 12(16): 2138 doi: 10.3390/ani12162138
|
| 21 |
Jian Sun, Jingxiao Zhang, Xiangfeng Wang, Fuxi Ji, Claudio Ronco, Jiakun Tian, Yongjie Yin. Gut-liver crosstalk in sepsis-induced liver injury. Critical Care 2020; 24(1) doi: 10.1186/s13054-020-03327-1
|
| 22 |
Henrik H. Hansen, Michael Feigh, Sanne S. Veidal, Kristoffer T. Rigbolt, Niels Vrang, Keld Fosgerau. Mouse models of nonalcoholic steatohepatitis in preclinical drug development. Drug Discovery Today 2017; 22(11): 1707 doi: 10.1016/j.drudis.2017.06.007
|
| 23 |
Sidhartha R. Sinha, Yeneneh Haileselassie, Linh P. Nguyen, Carolina Tropini, Min Wang, Laren S. Becker, Davis Sim, Karolin Jarr, Estelle T. Spear, Gulshan Singh, Hong Namkoong, Kyle Bittinger, Michael A. Fischbach, Justin L. Sonnenburg, Aida Habtezion. Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation. Cell Host & Microbe 2020; 27(4): 659 doi: 10.1016/j.chom.2020.01.021
|
| 24 |
V A Akhmedov, O V Gaus. Involvement of the hepatobiliary system and pancreas in obesity. Terapevticheskii arkhiv 2017; 89(1): 128 doi: 10.17116/terarkh2017891128-133
|
| 25 |
Zhang Lin, Wu Ye, Xianpeng Zu, Haisheng Xie, Houkai Li, Yiping Li, Weidong Zhang. Integrative metabolic and microbial profiling on patients with Spleen-yang-deficiency syndrome. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24130-7
|
| 26 |
Yangie Dwi Pinanga, Kyung-hee Pyo, Eun-Ae Shin, Haesong Lee, Eun Hae Lee, Wonsik Kim, Soyeon Kim, Ji Eon Kim, Semi Kim, Jung Weon Lee. Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development. Life Sciences 2024; 358: 123164 doi: 10.1016/j.lfs.2024.123164
|
| 27 |
Takashi Kobayashi, Michihiro Iwaki, Atsushi Nakajima, Asako Nogami, Masato Yoneda. Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome. International Journal of Molecular Sciences 2022; 23(19): 11689 doi: 10.3390/ijms231911689
|
| 28 |
Hongshan Li, Yingfei Xi, Xin Xin, Huajie Tian, Yiyang Hu. Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis. Nutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-020-00454-y
|
| 29 |
Yuyang Ma, Xue Liu, Defu Liu, Zihao Yin, Xinyi Yang, Mingyong Zeng. Oyster (Crassostrea gigas) Polysaccharide Ameliorates High-Fat-Diet-Induced Oxidative Stress and Inflammation in the Liver via the Bile Acid-FXR-AMPKα Pathway. Journal of Agricultural and Food Chemistry 2022; 70(28): 8662 doi: 10.1021/acs.jafc.2c02490
|
| 30 |
Xianzhi Liu, Lifu Wang, Siwei Tan, Zebin Chen, Bin Wu, Xiaoying Wu. Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.814871
|
| 31 |
Hanlin Zhang, Meng Dong, Xiaomeng Liu. Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat. Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10423
|
| 32 |
Claudia D. Fuchs, Michael Trauner. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nature Reviews Gastroenterology & Hepatology 2022; 19(7): 432 doi: 10.1038/s41575-021-00566-7
|
| 33 |
Milica Bozic, Carla Guzmán, Marta Benet, Sonia Sánchez-Campos, Carmelo García-Monzón, Eloi Gari, Sonia Gatius, José Manuel Valdivielso, Ramiro Jover. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis. Journal of Hepatology 2016; 65(4): 748 doi: 10.1016/j.jhep.2016.05.031
|
| 34 |
Fabio Marra, Gianluca Svegliati-Baroni. Lipotoxicity and the gut-liver axis in NASH pathogenesis. Journal of Hepatology 2018; 68(2): 280 doi: 10.1016/j.jhep.2017.11.014
|
| 35 |
Beatrice Anfuso, Claudio Tiribelli, Luciano Adorini, Natalia Rosso. Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58562-x
|
| 36 |
Yoshinao Kobayashi, Nagisa Hara, Ryosuke Sugimoto, Rumi Mifuji-Moroka, Hideaki Tanaka, Akiko Eguchi, Motoh Iwasa, Hiroshi Hasegawa, Kazuko Iwata, Yoshiyuki Takei, Osamu Taguchi. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD). Internal Medicine 2017; 56(7): 755 doi: 10.2169/internalmedicine.56.7796
|
| 37 |
Monica D. Chow, Yi-Horng Lee, Grace L. Guo. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Molecular Aspects of Medicine 2017; 56: 34 doi: 10.1016/j.mam.2017.04.004
|
| 38 |
V A Akhmedov, O V Gaus. Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2019; 91(2): 143 doi: 10.26442/00403660.2019.02.000051
|
| 39 |
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
|
| 40 |
Yingying Chen, Huang Su, Haibo Xue, Tingting Wang, Ting Qian, Chengwei Liao, Jinming Wu. Correlation between serum total bile acid and nonalcoholic fatty liver disease. Saudi Journal of Gastroenterology 2022; 28(4): 304 doi: 10.4103/sjg.sjg_512_21
|
| 41 |
Jie Hu, Wei Hong, Kan-Nan Yao, Xiao-Hong Zhu, Zhi-Yun Chen, Lei Ye. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway. World Journal of Gastroenterology 2019; 25(12): 1492-1501 doi: 10.3748/wjg.v25.i12.1492
|
| 42 |
Marleen Schonewille, Jan Freark de Boer, Albert K. Groen. Bile salts in control of lipid metabolism. Current Opinion in Lipidology 2016; 27(3): 295 doi: 10.1097/MOL.0000000000000303
|
| 43 |
Ting-ying Jiao, Yuan-di Ma, Xiao-zhen Guo, Yun-fei Ye, Cen Xie. Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease. Acta Pharmacologica Sinica 2022; 43(5): 1103 doi: 10.1038/s41401-022-00880-z
|
| 44 |
Wenkang Gao, Zhonglin Li, Huikuan Chu, Hang Yuan, Lilin Hu, Lin Yao, Li Zhang, Weijun Wang, Rong Lin, Ling Yang. Pharmacotherapy for Liver Cirrhosis and Its Complications. 2022; : 81 doi: 10.1007/978-981-19-2615-0_6
|
| 45 |
Aqsa Shahid, Stephen Chambers, Amy Scott-Thomas, Madhav Bhatia. Gut Microbiota and Liver Dysfunction in Sepsis: The Role of Inflammatory Mediators and Therapeutic Approaches. International Journal of Molecular Sciences 2024; 25(24): 13415 doi: 10.3390/ijms252413415
|
| 46 |
Wenzhao Jiang, Ruoyao Sang, Cai Zhang, Runting Yin, Zhen Ouyang, Yuan Wei. Application of small interfering RNA technology in cytochrome P450 gene modulation. Drug Metabolism and Disposition 2025; 53(3): 100040 doi: 10.1016/j.dmd.2025.100040
|
| 47 |
Eider Talavera-Urquijo, Marc Beisani, José M. Balibrea, John C. Alverdy. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. Surgery for Obesity and Related Diseases 2020; 16(9): 1361 doi: 10.1016/j.soard.2020.03.013
|
| 48 |
Fabiana de Faria Ghetti, Daiane Gonçalves Oliveira, Juliano Machado de Oliveira, Lincoln Eduardo Villela Vieira de Castro Ferreira, Dionéia Evangelista Cesar, Ana Paula Boroni Moreira. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. European Journal of Nutrition 2018; 57(3): 861 doi: 10.1007/s00394-017-1524-x
|
| 49 |
Juan P. Arab, Saul J. Karpen, Paul A. Dawson, Marco Arrese, Michael Trauner. Bile acids and nonalcoholic fatty liver disease. Hepatology 2017; 65(1): 350 doi: 10.1002/hep.28709
|
| 50 |
Liping Yang, Mingyu Liu, Mengjuan Zhao, Shaoyang Zhi, Wenlei Zhang, Leya Qu, Jinrui Xiong, Xiao Yan, Chaobin Qin, Guoxing Nie, Shengpeng Wang, Jiting Wang. Dietary Bile Acid Supplementation Could Regulate the Glucose, Lipid Metabolism, and Microbiota of Common Carp (Cyprinus carpio L.) Fed with a High-Lipid Diet. Aquaculture Nutrition 2023; 2023: 1 doi: 10.1155/2023/9953927
|
| 51 |
Yaodi Shao, Suzhen Chen, Liu Han, Junli Liu. Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention. Nutrition & Metabolism 2023; 20(1) doi: 10.1186/s12986-023-00748-x
|
| 52 |
Lukasz Kaska, Tomasz Sledzinski, Agnieszka Chomiczewska, Agnieszka Dettlaff-Pokora, Julian Swierczynski. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World Journal of Gastroenterology 2016; 22(39): 8698-8719 doi: 10.3748/wjg.v22.i39.8698
|
| 53 |
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiota. Molecular Metabolism 2016; 5(9): 782 doi: 10.1016/j.molmet.2016.06.003
|
| 54 |
Yanjiao Ruan, Rong Liu, Lingzhi Gong. Investigation of dysregulated lipid metabolism in diabetic mice via targeted metabolomics of bile acids in enterohepatic circulation. Rapid Communications in Mass Spectrometry 2022; 36(6) doi: 10.1002/rcm.9236
|
| 55 |
Xinmu Zhang, Ruitang Deng. Nonalcoholic Fatty Liver Disease - An Update. 2019; doi: 10.5772/intechopen.81474
|
| 56 |
Hikari Kusu, Hiroki Yoshida, Michiko Kudo, Mai Okuyama, Naoki Harada, Kentaro Tsuji‐Naito, Mitsugu Akagawa. Tomatidine Reduces Palmitate‐Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor‐Mediated Signaling in Human HepG2 Hepatocytes. Molecular Nutrition & Food Research 2019; 63(22) doi: 10.1002/mnfr.201801377
|
| 57 |
Aaron Yeoh, Robert Wong, Ashwani K. Singal. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2023; 27(2): 413 doi: 10.1016/j.cld.2023.01.009
|
| 58 |
Wenke Feng, Craig McClain. Molecules, Systems and Signaling in Liver Injury. 2017; : 251 doi: 10.1007/978-3-319-58106-4_11
|
| 59 |
Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, Gyorgy Baffy, Agostino Di Ciaula. Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. International Journal of Molecular Sciences 2024; 25(11): 5640 doi: 10.3390/ijms25115640
|
| 60 |
Qinwei Yu, Zhenzhou Jiang, Luyong Zhang. Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 190: 81 doi: 10.1016/j.pharmthera.2018.04.005
|
| 61 |
Vincent Wai-Sun Wong, Shiv Chitturi, Grace Lai-Hung Wong, Jun Yu, Henry Lik-Yuen Chan, Geoffrey C Farrell. Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. The Lancet Gastroenterology & Hepatology 2016; 1(1): 56 doi: 10.1016/S2468-1253(16)30011-5
|
| 62 |
Hong Yao, Yu-Jie Qiao, Ya-Li Zhao, Xu-Feng Tao, Li-Na Xu, Lian-Hong Yin, Yan Qi, Jin-Yong Peng. Herbal medicines and nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(30): 6890-6905 doi: 10.3748/wjg.v22.i30.6890
|
| 63 |
Xinyu Li, Shixuan Zheng, Xuekun Ma, Kaimin Cheng, Guoyao Wu. Effects of dietary protein and lipid levels on the growth performance, feed utilization, and liver histology of largemouth bass (Micropterus salmoides). Amino Acids 2020; 52(6-7): 1043 doi: 10.1007/s00726-020-02874-9
|